Full Name
Lingzhi Wang
Variants
Wang Lingzhi
Wang, L.Z.
Wang, L.-Z.
Wang, L.
 
 
 
Email
phcwl@nus.edu.sg
 
 

Publications

Refined By:
Date Issued:  [2000 TO 2021]
Type:  Article
Department:  PHYSIOLOGY

Results 1-4 of 4 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)
12018Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressorSubhash, V.V; Yeo, M.S; Wang, L ; Tan, S.H; Wong, F.Y; Thuya, W.L ; Tan, W.L; Peethala, P.C ; Soe, M.Y; Tan, D.S.P; Padmanabhan, N ; Baloglu, E; Shacham, S; Tan, P ; Koeffler, H.P ; Yong, W.P 
22015Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkersLi F. ; Shanmugam M.K. ; Siveen K.S. ; Wang F. ; Ong T.H.; Loo S.Y. ; Swamy M.M.M.; Mandal S.; Kumar A.P. ; Goh B.C. ; Kundu T.; Ahn K.S.; Wang L.Z. ; Hui K.M. ; Sethi G. 
328-Mar-2018Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signalingWang, Lingzhi ; Syn, Nicholas Li-Xun; Subhash, Vinod Vijay; Any, Yijia; Thuya, Win Lwin ; Cheow, Esther Sok Hwee ; Kong, Li Ren ; Yu, Fenggang ; Peethala, Praveen C. ; Wong, Andrea Li-Ann ; Laljibhai, Hirpara J. ; Chinnathambi, Arunachalam; Ong, Pei Shi ; Ho, Paul Chi-Lui ; Sethi, Gautam ; Yong, Wei Peng ; Goh, Boon Cher 
42015Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignanciesWong, Andrea; Soo, Ross A.; Tan, Daniel; Lee, Soo Chin ; Lim, Joline S J; Marban, P.C.; Kong, Li Ren ; Lee, Youngjoo; Wang, Lingzhi ; Thuya, Win Lwin ; Soong, R.; Yee, M.Q.; Chin, T.M.; Cordero, Maricel Tiemsim; Asuncion, Bernadette Reyna ; Pang, B.; Pervaiz, Shazib ; Hirpara, Jayshree L. ; Sinha, Arvind; Xu, W.W.; Yuasa, M.; Tsunoda, T.; Motoyama, M.; Yamauchi, T.; Goh, Boon Cher